Original Research

Published in:
Volume 6 / Year 2017 / Issue 2

Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey

Author(s): 1 Sabine Vogler, PhD, Peter Schneider, MA
Page: 79-88

Introduction/Study objective: This paper aims to survey the policies implemented by European countries for pricing and promoting the use of biosimilar medicines and to explore similarities and differences with policies… Read More »

What pricing and reimbursement policies to use for off-patent biologicals in Europe? – results from the second EBE biological medicines policy survey

Author(s): Alexander Roediger, MA, Executive MBA, Barbara Freischem, Jean-Baptiste Reiland, MSc
Page: 61-78

Author byline as per print journal: Jean-Baptiste Reiland, MSc; Barbara Freischem; Alexander Roediger, MA Introduction/Study objective Biosimilar policies with a focus on uptake have received a lot of attention at national… Read More »

Go Back Print